SCHEMBL7507807

SCHEMBL7507807

Cc1cccc(C)c1-c1nc(Cc2ccccc2)oc1-c1ccc(S(N)(=O)=O)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXRA P19793 2/20 0.54
▸ CA1 P00915 8/20 0.49
▸ CA2 P00918 8/20 0.49
▸ CA9 Q16790 6/20 0.49
▸ CA12 O43570 4/20 0.49
▸ CA14 Q9ULX7 2/20 0.49
▸ PTGS2 P35354 10/20 0.46
▸ PTGS1 P23219 7/20 0.46
▸ MT-CO2 P00403 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ CA3 P07451 1/20 0.44
▸ ADRB2 P07550 1/20 0.44
▸ ADRB1 P08588 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ ADORA3 P0DMS8 1/20 0.44
▸ CHRM1 P11229 1/20 0.44
▸ ADRA2B P18089 1/20 0.44
▸ CA4 P22748 1/20 0.44
▸ CA6 P23280 1/20 0.44
▸ SLC6A2 P23975 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7497700 0.93 RXRA (0.47) RXRACA1CA2CA9CA12
SCHEMBL7506168 0.93 RXRA (0.47) RXRACA1CA2CA9CA12
SCHEMBL7503769 0.91 CA1 (0.49) RXRACA1CA2CA9CA12
SCHEMBL7501104 0.91 RXRA (0.54) RXRAPTGS2PTGS1LMNARXRB
SCHEMBL7504983 0.90 RXRA (0.53) RXRACA1CA2CA9CA12
SCHEMBL7502817 0.88 CA1 (0.48) RXRACA1CA2CA9CA12
SCHEMBL7502918 0.88 CA1 (0.48) RXRACA1CA2CA9CA12
SCHEMBL7500801 0.87 RXRA (0.53) RXRACA1CA2CA9CA12
SCHEMBL7503904 0.87 RXRA (0.53) RXRACA1CA2CA9CA12
SCHEMBL7506477 0.87 CA2 (0.52) RXRACA1CA2CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0699192-B1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-07-24 — — EP disclosed
US-6090834-A ANALGESICS; RHEUMATIC DISORDERS; SKIN DISORDERS; GASTROINTESTINAL DISORDERS G.D. SEARLE & CO. (US) 2000-07-18 — — US disclosed
EP-0825989-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-03-04 — — EP disclosed
WO-1996036617-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-11-21 — — WO disclosed
Send feedback